GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » Common Stock

EKTAF (Elekta AB) Common Stock : $0 Mil (As of Jul. 2024)


View and export this data going back to . Start your Free Trial

What is Elekta AB Common Stock?

Elekta AB's quarterly common stock increased from Jan. 2024 ($0 Mil) to Apr. 2024 ($18 Mil) but then declined from Apr. 2024 ($18 Mil) to Jul. 2024 ($0 Mil).

Elekta AB's annual common stock declined from Apr. 2022 ($20 Mil) to Apr. 2023 ($19 Mil) and declined from Apr. 2023 ($19 Mil) to Apr. 2024 ($18 Mil).


Elekta AB Common Stock Historical Data

The historical data trend for Elekta AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Common Stock Chart

Elekta AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.17 22.59 20.09 18.55 17.75

Elekta AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 17.75 -

Elekta AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Elekta AB Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.